Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Mannan-conjugated adenovirus enhanced gene therapy effects on murine hepatocellular carcinoma cells in vitro and in vivo.

Liu Z, Ke F, Duan C, Lan H, Li J, Gao C, Li J, Zhong Z.

Bioconjug Chem. 2013 Aug 21;24(8):1387-97.

PMID:
23937094
2.

Mannan-modified Ad5-PTEN treatment combined with docetaxel improves the therapeutic effect in H22 tumor-bearing mice.

Liu Z, Li J, Li J, Huang J, Ke F, Qi Q, Jiang X, Zhong Z.

Int J Nanomedicine. 2012;7:5039-49. doi: 10.2147/IJN.S34022. Epub 2012 Sep 17.

3.

A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.

Li Y, Yu DC, Chen Y, Amin P, Zhang H, Nguyen N, Henderson DR.

Cancer Res. 2001 Sep 1;61(17):6428-36.

4.

Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma.

Chen W, Wu Y, Liu W, Wang G, Wang X, Yang Y, Chen W, Tai Y, Lu M, Qian Q, Zhang Q, Chen G.

Cancer Lett. 2011 Aug 1;307(1):93-103. doi: 10.1016/j.canlet.2011.03.021. Epub 2011 Apr 19.

PMID:
21504839
5.

Combined use of chemotherapeutics and oncolytic adenovirus in treatment of AFP-expressing hepatocellular carcinoma.

Mao CY, Hua HJ, Chen P, Yu DC, Cao J, Teng LS.

Hepatobiliary Pancreat Dis Int. 2009 Jun;8(3):282-7.

6.

Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin.

Ma B, Wang Y, Zhou X, Huang P, Zhang R, Liu T, Cui C, Liu X, Wang Y.

J Cancer Res Clin Oncol. 2015 Mar;141(3):419-29. doi: 10.1007/s00432-014-1835-8. Epub 2014 Sep 21.

PMID:
25240826
7.

The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma.

Li J, Liu H, Li L, Wu H, Wang C, Yan Z, Wang Y, Su C, Jin H, Zhou F, Wu M, Qian Q.

Oncol Rep. 2013 Mar;29(3):895-902. doi: 10.3892/or.2012.2217. Epub 2012 Dec 28.

8.

Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1.

Wirth T, Kühnel F, Fleischmann-Mundt B, Woller N, Djojosubroto M, Rudolph KL, Manns M, Zender L, Kubicka S.

Cancer Res. 2005 Aug 15;65(16):7393-402.

9.

[Construction of adenovirus carrying dual-target shRNA for Oct-4 and Survivin and its inhibitory effect on human hepatocellular carcinoma cells].

Wang D, Wang J, Li L, Chen J, Su C.

Sheng Wu Gong Cheng Xue Bao. 2012 May;28(5):623-31. Chinese.

PMID:
22916500
10.

Synergistic tumor suppression by adenovirus-mediated inhibitor of growth 4 and interleukin-24 gene cotransfer in hepatocarcinoma cells.

Xie Y, Lv H, Sheng W, Miao J, Xiang J, Yang J.

Cancer Biother Radiopharm. 2011 Dec;26(6):681-95. doi: 10.1089/cbr.2011.1047. Epub 2011 Oct 11.

PMID:
21988227
11.

Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.

Wei RC, Cao X, Gui JH, Zhou XM, Zhong D, Yan QL, Huang WD, Qian QJ, Zhao FL, Liu XY.

Hum Gene Ther. 2011 Sep;22(9):1109-19. doi: 10.1089/hum.2010.219. Epub 2011 Apr 21.

PMID:
21361790
12.

Recombinant adenovirus encoding FAT10 small interfering RNA inhibits HCC growth in vitro and in vivo.

Chen J, Yang L, Chen H, Yuan T, Liu M, Chen P.

Exp Mol Pathol. 2014 Apr;96(2):207-11. doi: 10.1016/j.yexmp.2014.01.001. Epub 2014 Jan 14.

PMID:
24440736
13.

Targeting gene-virus-mediated manganese superoxide dismutase effectively suppresses tumor growth in hepatocellular carcinoma in vitro and in vivo.

Huang F, Ma B, Wang Y, Xiao R, Kong Y, Zhou X, Xia D.

Cancer Biother Radiopharm. 2014 Dec;29(10):403-11. doi: 10.1089/cbr.2014.1642.

PMID:
25414976
14.

Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.

Chen L, Yuan YF, Li Y, Chan TH, Zheng BJ, Huang J, Guan XY.

Gut. 2011 Apr;60(4):534-43. doi: 10.1136/gut.2010.224071. Epub 2010 Nov 10.

PMID:
21068133
15.

Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.

Kanai F, Shiratori Y, Yoshida Y, Wakimoto H, Hamada H, Kanegae Y, Saito I, Nakabayashi H, Tamaoki T, Tanaka T, Lan KH, Kato N, Shiina S, Omata M.

Hepatology. 1996 Jun;23(6):1359-68.

PMID:
8675152
16.

Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system.

Jing P, Cao S, Xiao S, Zhang X, Ke S, Ke F, Yu X, Wang L, Wang S, Luo Y, Zhong Z.

Cancer Lett. 2016 Dec 28;383(2):230-242. doi: 10.1016/j.canlet.2016.10.003. Epub 2016 Oct 6.

PMID:
27721020
17.

An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma.

Li X, Su Y, Sun B, Ji W, Peng Z, Xu Y, Wu M, Su C.

Mol Cancer Ther. 2016 Jul;15(7):1436-51. doi: 10.1158/1535-7163.MCT-16-0096. Epub 2016 May 18.

18.

Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.

Zhao JJ, Pan K, Li JJ, Chen YB, Chen JG, Lv L, Wang DD, Pan QZ, Chen MS, Xia JC.

PLoS One. 2011;6(10):e26608. doi: 10.1371/journal.pone.0026608. Epub 2011 Oct 19.

19.

Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma.

Zhu LM, Shi DM, Dai Q, Cheng XJ, Yao WY, Sun PH, Ding Y, Qiao MM, Wu YL, Jiang SH, Tu SP.

Oncotarget. 2014 Jul 30;5(14):5403-15.

20.

ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis.

Yun CO, Kim E, Koo T, Kim H, Lee YS, Kim JH.

Cancer Gene Ther. 2005 Jan;12(1):61-71.

PMID:
15375379

Supplemental Content

Support Center